Fmr Llc

Insider Reports History

Entity
Company
Location
245 Summer Street, Boston, MA
Signature
Stephanie J. Brown, Duly authorized under Powers of Attorney, by and on behalf of FMR LLC and its direct and indirect subsidiaries, and Abigail P. Johnson
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Fmr Llc:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Flywire Corp Other* Common Stock 7.27M $135M $18.58 May 28, 2021 F-Prime Capital Partners Tech Fund LP
Toast, Inc. Other* Class B Common Stock 6.7M $113M $16.92 Nov 9, 2021 F-Prime Capital Partners Tech Fund LP
Beam Therapeutics Inc. Other* Common Stock 2.77M $85.7M $30.93 Feb 13, 2024 Shares held by persons and entities whose shares are subject to reporting by the undersigned
Neumora Therapeutics, Inc. Other* Common Stock 5.47M $65.6M $11.98 Sep 19, 2023 F-Prime Capital Partners Life Sciences Fund VII LP
Prime Medicine, Inc. Other* Common Stock 4.23M $63.3M $14.97 Oct 24, 2022 Entity managed by Impresa Management LLC whose shares are subject to reporting by the Undersigned
Prime Medicine, Inc. Other* Common Stock 4.12M $61.7M $14.97 Oct 24, 2022 F-Prime Capital Partners Life Sciences Fund VI LP
Structure Therapeutics Inc. Other*, 10%+ Owner American Depositary Shares 1.54M $54M $35.00 Apr 17, 2024 Shares held by persons and entities whose shares are subject to reporting by the undersigned
Sana Biotechnology, Inc. Other*, 10%+ Owner Common Stock 4.83M $45.7M $9.45 Apr 1, 2024 F-Prime Capital Partners Life Sciences Fund VI LP
Beam Therapeutics Inc. Other* Common Stock 1.24M $38.7M $31.34 Feb 14, 2024 F-Prime Capital Partners Healthcare Fund V LP
Rallybio Corp Other* Common Stock 1.69M $13.9M $8.20 Aug 2, 2021 F-Prime Capital Partners Life Sciences Fund VI LP
Verve Therapeutics, Inc. Other* Common Stock 571K $5.71M $10.00 Jul 26, 2022 F-Prime Capital Partners Healthcare Fund V LP
Caribou Biosciences, Inc. Other* Common Stock 1.84M $5.45M $2.96 Jul 27, 2021 F-Prime Capital Partners Healthcare Fund IV LP
Caribou Biosciences, Inc. Other* Common Stock 1.46M $4.34M $2.96 Jul 27, 2021 Impresa Fund III Limited Partnership
Prime Medicine, Inc. Other* Common Stock 110K $1.65M $14.97 Oct 24, 2022 F-Prime Capital Partners Life Sciences Advisors Fund VI LP
Xilio Therapeutics, Inc. Other* Common Stock 1.53M $1.27M $0.83 Oct 26, 2021 F-Prime Capital Partners Healthcare Fund IV LP
Structure Therapeutics Inc. Other*, 10%+ Owner American Depositary Shares 32.2K $1.13M $35.00 Apr 17, 2024 F-Prime Capital Partners Life Sciences Fund VI LP
Neumora Therapeutics, Inc. Other* Common Stock 88.3K $1.06M $11.98 Sep 19, 2023 FBRI LLC
Neumora Therapeutics, Inc. Other* Common Stock 63.7K $763K $11.98 Sep 19, 2023 F-Prime Inc.
Xilio Therapeutics, Inc. Other* Common Stock 372K $309K $0.83 Oct 26, 2021 Impresa Fund III Limited Partnership
Structure Therapeutics Inc. Other*, 10%+ Owner American Depositary Shares 2.73K $95.7K $35.00 Apr 17, 2024 F-Prime Capital Partners Life Sciences Advisors Fund VI LP
Caribou Biosciences, Inc. Other* Common Stock 17.6K $52K $2.96 Jul 27, 2021 F-Prime Capital Partners Healthcare Advisors Fund IV LP
Fidelity Private Credit Fund Other* Class D Common Shares of Beneficial Interest 398 $10.2K $25.54 Jan 29, 2024 FMR Capital Inc.
Fidelity Private Credit Fund Other* Class S Common Shares of Beneficial Interest 398 $10.2K $25.54 Jan 29, 2024 FMR Capital Inc.
Xilio Therapeutics, Inc. Other* Common Stock 4.47K $3.71K $0.83 Oct 26, 2021 F-Prime Capital Partners Healthcare Advisors Fund IV LP
Structure Therapeutics Inc. Other*, 10%+ Owner American Depositary Shares 41 $1.44K $35.00 Apr 17, 2024 FIMM, LLC
Fidelity Multi-Strategy Credit Fund Other*, 10%+ Owner Common Shares of Beneficial Ownership 2.5M May 19, 2023 Direct
Fidelity Private Credit Fund Other* Class I Common Shares of Beneficial Interest 1.28M Jan 29, 2024 Direct
Bicara Therapeutics Inc. Other* Common Stock 1.12M Sep 16, 2024 F-Prime Capital Partners Life Sciences Fund VII LP
Turnstone Biologics Corp. Other* Common Stock 833K Jan 9, 2024 F-Prime Capital Partners Healthcare Fund V LP
Structure Therapeutics Inc. Other*, 10%+ Owner Ordinary Shares 531K Jun 6, 2024 F-Prime Capital Partners Life Sciences Fund VI LP
Fidelity Private Credit Fund Other* Class I Common Shares of Beneficial Interest 352K Jan 29, 2024 Fidelity Multi-Strategy Credit Fund
Turnstone Biologics Corp. Other* Common Stock 296K Jan 9, 2024 Impresa Fund III Limited Partnership
Structure Therapeutics Inc. Other*, 10%+ Owner Ordinary Shares 45.1K Jun 6, 2024 F-Prime Capital Partners Life Sciences Advisors Fund VI LP
Turnstone Biologics Corp. Other* Common Stock 4.94K Jan 9, 2024 F-Prime Capital Partners Healthcare Advisors Fund V LP
Fidelity Private Credit Fund Other* Class I Common Shares of Beneficial Interest 86.1 Jan 29, 2024 FMR Capital Inc.
Bicara Therapeutics Inc. Other* Series B Preferred Stock 0 Sep 16, 2024 F-Prime Capital Partners Life Sciences Fund VII LP
Bicara Therapeutics Inc. Other* Series C Preferred Stock 0 Sep 16, 2024 F-Prime Capital Partners Life Sciences Fund VII LP
Bicara Therapeutics Inc. Other* Series Seed Preferred Stock 0 Sep 16, 2024 F-Prime Capital Partners Life Sciences Fund VII LP
Caribou Biosciences, Inc. Other* Series A-1 Preferred Stock 0 Jul 27, 2021 F-Prime Capital Partners Healthcare Advisors Fund IV LP
Caribou Biosciences, Inc. Other* Series A-1 Preferred Stock 0 Jul 27, 2021 F-Prime Capital Partners Healthcare Fund IV LP
Caribou Biosciences, Inc. Other* Series A-1 Preferred Stock 0 Jul 27, 2021 Impresa Fund III Limited Partnership
Caribou Biosciences, Inc. Other* Series B Preferred Stock 0 Jul 27, 2021 F-Prime Capital Partners Healthcare Fund IV LP
Flywire Corp Other* Series A Preferred Stock 0 May 28, 2021 F-Prime Capital Partners Tech Fund LP
Flywire Corp Other* Series B-1 NV Preferred Stock 0 May 28, 2021 F-Prime Capital Partners Tech Fund LP
Flywire Corp Other* Series B-1 Preferred Stock 0 May 28, 2021 F-Prime Capital Partners Tech Fund LP
Flywire Corp Other* Series B Preferred Stock 0 May 28, 2021 F-Prime Capital Partners Tech Fund LP
Flywire Corp Other* Series C Preferred Stock 0 May 28, 2021 F-Prime Capital Partners Tech Fund LP
Neumora Therapeutics, Inc. Other* Series A-2 Preferred Stock 0 Sep 19, 2023 FBRI LLC
Neumora Therapeutics, Inc. Other* Series A-2 Preferred Stock 0 Sep 19, 2023 F-Prime Capital Partners Life Sciences Fund VII LP
Neumora Therapeutics, Inc. Other* Series A-2 Preferred Stock 0 Sep 19, 2023 F-Prime Inc.
Neumora Therapeutics, Inc. Other* Series B Preferred Stock 0 Sep 19, 2023 F-Prime Capital Partners Life Sciences Fund VII LP
Prime Medicine, Inc. Other* Series A Convertible Preferred Stock 0 Oct 24, 2022 Entity managed by Impresa Management LLC whose shares are subject to reporting by the Undersigned
Prime Medicine, Inc. Other* Series A Convertible Preferred Stock 0 Oct 24, 2022 F-Prime Capital Partners Life Sciences Advisors Fund VI LP
Prime Medicine, Inc. Other* Series A Convertible Preferred Stock 0 Oct 24, 2022 F-Prime Capital Partners Life Sciences Fund VI LP
Prime Medicine, Inc. Other* Series B Convertible Preferred Stock 0 Oct 24, 2022 Entity managed by Impresa Management LLC whose shares are subject to reporting by the Undersigned
Prime Medicine, Inc. Other* Series B Convertible Preferred Stock 0 Oct 24, 2022 F-Prime Capital Partners Life Sciences Advisors Fund VI LP
Rallybio Corp Other* Series B Preferred Units 0 Aug 2, 2021 F-Prime Capital Partners Life Sciences Fund VI LP
Turnstone Biologics Corp. Other* Series B-1 Preferred Stock 0 Jul 25, 2023 F-Prime Capital Partners Healthcare Fund V LP
Turnstone Biologics Corp. Other* Series B-2 Preferred Stock 0 Jul 25, 2023 F-Prime Capital Partners Healthcare Advisors Fund V LP
Turnstone Biologics Corp. Other* Series B-2 Preferred Stock 0 Jul 25, 2023 F-Prime Capital Partners Healthcare Fund V LP
Turnstone Biologics Corp. Other* Series B-2 Preferred Stock 0 Jul 25, 2023 Impresa Fund III Limited Partnership
Turnstone Biologics Corp. Other* Series C Preferred Stock 0 Jul 25, 2023 F-Prime Capital Partners Healthcare Fund V LP
Turnstone Biologics Corp. Other* Series D Preferred Stock 0 Jul 25, 2023 F-Prime Capital Partners Healthcare Fund V LP
Xilio Therapeutics, Inc. Other* Series A-1 Preferred Stock 0 Oct 26, 2021 F-Prime Capital Partners Healthcare Fund IV LP
Xilio Therapeutics, Inc. Other* Series A Preferred Stock 0 Oct 26, 2021 F-Prime Capital Partners Healthcare Fund IV LP
Xilio Therapeutics, Inc. Other* Series B Preferred Stock 0 Oct 26, 2021 F-Prime Capital Partners Healthcare Advisors Fund IV LP
Xilio Therapeutics, Inc. Other* Series B Preferred Stock 0 Oct 26, 2021 F-Prime Capital Partners Healthcare Fund IV LP
Xilio Therapeutics, Inc. Other* Series B Preferred Stock 0 Oct 26, 2021 Impresa Fund III Limited Partnership

Insider Reports Filed by Fmr Llc

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BCAX Bicara Therapeutics Inc. Sep 16, 2024 6 $0 4 Sep 18, 2024 Other*
BCAX Bicara Therapeutics Inc. Sep 12, 2024 0 $0 3 Sep 12, 2024 Other*, 10%+ Owner
GPCR Structure Therapeutics Inc. Jun 6, 2024 0 $0 3 Jun 13, 2024 Other*, 10%+ Owner
GPCR Structure Therapeutics Inc. Apr 17, 2024 0 $0 4 Apr 19, 2024 Other*
SANA Sana Biotechnology, Inc. Apr 1, 2024 0 $0 3 Apr 8, 2024 Other*, 10%+ Owner
GPCR Structure Therapeutics Inc. Mar 14, 2024 1 -$770K 4 Mar 18, 2024 Other*, 10%+ Owner
BEAM Beam Therapeutics Inc. Feb 13, 2024 4 -$27.5M 4 Feb 15, 2024 Other*
GPCR Structure Therapeutics Inc. Feb 13, 2024 1 -$24.8K 4 Feb 15, 2024 Other*, 10%+ Owner
NONE Fidelity Private Credit Fund Jan 29, 2024 0 $0 4 Jan 31, 2024 Other*
TSBX Turnstone Biologics Corp. Jan 9, 2024 0 $0 4 Jan 11, 2024 Other*
BEAM Beam Therapeutics Inc. Dec 22, 2023 1 $0 4 Dec 27, 2023 Other*, 10%+ Owner
GPCR Structure Therapeutics Inc. Dec 22, 2023 1 $0 4 Dec 27, 2023 Other*, 10%+ Owner
GPCR Structure Therapeutics Inc. Dec 5, 2023 2 -$1.09M 4 Dec 7, 2023 Other*, 10%+ Owner
NONE Fidelity Private Credit Fund Nov 29, 2023 2 $20K 4 Nov 29, 2023 Other*, 10%+ Owner
GPCR Structure Therapeutics Inc. Oct 18, 2023 2 -$1.15M 4 Oct 23, 2023 Other*, 10%+ Owner
GPCR Structure Therapeutics Inc. Oct 2, 2023 0 $0 3 Oct 12, 2023 Other*, 10%+ Owner
NMRA Neumora Therapeutics, Inc. Sep 19, 2023 8 $0 4 Sep 21, 2023 Other*
NMRA Neumora Therapeutics, Inc. Sep 14, 2023 0 $0 3 Sep 14, 2023 Other*, 10%+ Owner
TSBX Turnstone Biologics Corp. Jul 25, 2023 12 $0 4 Jul 27, 2023 Other*, 10%+ Owner
TSBX Turnstone Biologics Corp. Jul 20, 2023 0 $0 3 Jul 20, 2023 Other*, 10%+ Owner
NONE Fidelity Private Credit Fund Jun 27, 2023 1 $8.75M 4 Jun 29, 2023 Other*, 10%+ Owner
NONE Fidelity Multi-Strategy Credit Fund May 19, 2023 0 $0 3 May 26, 2023 Other*, 10%+ Owner
NONE Fidelity Private Credit Fund Mar 13, 2023 0 $0 3 Mar 23, 2023 Other*, 10%+ Owner
GPCR Structure Therapeutics Inc. Feb 7, 2023 18 $0 4 Feb 9, 2023 Other*
GPCR Structure Therapeutics Inc. Feb 2, 2023 0 $0 3 Feb 2, 2023 Other*, 10%+ Owner
PRME Prime Medicine, Inc. Oct 24, 2022 10 $0 4 Oct 26, 2022 Other*
PRME Prime Medicine, Inc. Oct 19, 2022 0 $0 3 Oct 19, 2022 Other*, 10%+ Owner
BEAM Beam Therapeutics Inc. Sep 6, 2022 3 -$29.9K 4 Sep 8, 2022 Other*, 10%+ Owner
BEAM Beam Therapeutics Inc. Aug 4, 2022 9 -$1.23M 4 Aug 8, 2022 Other*, 10%+ Owner
VERV Verve Therapeutics, Inc. Jul 26, 2022 0 $0 4 Jul 28, 2022 Other*
VERV Verve Therapeutics, Inc. Jul 12, 2022 2 -$3.39M 4 Jul 14, 2022 Other*, 10%+ Owner
VERV Verve Therapeutics, Inc. Jul 1, 2022 1 -$607K 4 Jul 6, 2022 Other*, 10%+ Owner
VERV Verve Therapeutics, Inc. Jun 29, 2022 3 -$822K 4 Jul 1, 2022 Other*, 10%+ Owner
BEAM Beam Therapeutics Inc. Apr 12, 2022 11 -$981K 4 Apr 14, 2022 Other*, 10%+ Owner
VERV Verve Therapeutics, Inc. Mar 9, 2022 1 -$115K 4 Mar 11, 2022 Other*, 10%+ Owner
VERV Verve Therapeutics, Inc. Feb 9, 2022 1 -$389K 4 Feb 11, 2022 Other*, 10%+ Owner
VERV Verve Therapeutics, Inc. Feb 1, 2022 1 -$1.03M 4 Feb 3, 2022 Other*, 10%+ Owner
VERV Verve Therapeutics, Inc. Jan 26, 2022 5 -$4.94M 4 Jan 28, 2022 Other*, 10%+ Owner
BEAM Beam Therapeutics Inc. Jan 20, 2022 0 $0 3 Jan 24, 2022 Other*, 10%+ Owner
VERV Verve Therapeutics, Inc. Dec 23, 2021 0 $0 3 Dec 28, 2021 Other*, 10%+ Owner
TOST Toast, Inc. Nov 9, 2021 0 $0 4 Nov 12, 2021 Other*
XLO Xilio Therapeutics, Inc. Oct 26, 2021 10 $0 4 Oct 28, 2021 Other*
XLO Xilio Therapeutics, Inc. Oct 21, 2021 0 $0 3 Oct 21, 2021 Other*, 10%+ Owner
TOST Toast, Inc. Sep 24, 2021 0 $0 3 Oct 4, 2021 Other*, 10%+ Owner
BEAM Beam Therapeutics Inc. Aug 24, 2021 7 $0 4 Aug 26, 2021 Other*
BEAM Beam Therapeutics Inc. Aug 6, 2021 7 $0 4/A Aug 16, 2021 Other*, 10%+ Owner
RLYB Rallybio Corp Aug 2, 2021 2 $0 4 Aug 4, 2021 Other*
RLYB Rallybio Corp Jul 29, 2021 0 $0 3 Jul 29, 2021 Other*, 10%+ Owner
CRBU Caribou Biosciences, Inc. Jul 27, 2021 8 $0 4 Jul 29, 2021 Other*
CRBU Caribou Biosciences, Inc. Jul 22, 2021 0 $0 3 Jul 22, 2021 Other*, 10%+ Owner
VERV Verve Therapeutics, Inc. Jun 21, 2021 4 $0 4 Jun 23, 2021 Other*
VERV Verve Therapeutics, Inc. Jun 16, 2021 0 $0 3 Jun 16, 2021 Other*, 10%+ Owner
FLYW Flywire Corp May 28, 2021 10 $0 4 Jun 2, 2021 Other*
FLYW Flywire Corp May 25, 2021 0 $0 3 May 26, 2021 Other*, 10%+ Owner